The company’s clinical research team, led by Dawna Salter-Farfan and Jennifer L. Murphy, will showcase evidence regarding their branded ingredients. One primary focus is the Kinexa Joint Longevity Complex, with a study detailing how the herbal supplement improved MRI-detected knee structure and physical mobility in adults with osteoarthritis. A second presentation evaluates the Dynagenix Joint+Muscle Formula, a Boswellia serrata extract shown to reduce pain and stiffness within five days.
Beyond mobility, the team will present a pre-clinical study utilizing the Caenorhabditis elegans model to examine a galloylated catechin dimer-rich green tea extract. This research identifies specific pathways related to intestinal barrier integrity and stress resilience. Steve Fink, Vice President of Marketing, noted that these presentations reinforce the company's commitment to building a rigorous scientific foundation for its portfolio, aiming to drive innovation and consumer confidence through clinically supported evidence.
Comments (0)
No comments yet. Be the first!